RUNX1 mediates the therapeutic effects of mesenchymal stem cells-derived microparticles in acute respiratory distress syndrome
Clin Transl Med
.
2023 Nov;13(11):e1455.
doi: 10.1002/ctm2.1455.
Authors
Dan Predescu
1
,
Shanshan Qin
1
,
Vasilios Stefanis
2
,
Brandon Carman
1
,
Balaji Ganesh
3
,
Kanika Sharma
1
,
Babak Mokhlesi
1
,
Sanda Predescu
1
Affiliations
1
Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA.
2
Rush University Medical Center, Chicago, Illinois, USA.
3
Department of Pharmacology, University of Illinois Chicago, Chicago, Illinois, USA.
PMID:
37955231
PMCID:
PMC10641787
DOI:
10.1002/ctm2.1455
No abstract available
Publication types
Letter
MeSH terms
Core Binding Factor Alpha 2 Subunit
Humans
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stem Cells*
Respiratory Distress Syndrome* / therapy
Substances
Core Binding Factor Alpha 2 Subunit
RUNX1 protein, human
Grants and funding
R01 HL127022/HL/NHLBI NIH HHS/United States